Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001178913-25-003007·Capital Point Ltd.
Schedule 13G ownership disclosure
NASUS PHARMA LTD
Ordinary Shares, no par value · CUSIP: M7071P109
Event date: 2025-08-14
- Filing-level shares
- 575,129
- Percent of class
- 6.35%
- Capital Point Ltd.
Shares: 575,129 · Class: 6.35%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-25-003007
- Form type
- SCHEDULE 13G
- Filer
- Capital Point Ltd.
- CIK
- CIK 1634113
- Filed
- Aug 20, 2025
- Reporting period
- Aug 14, 2025
- Description
- Schedule 13G beneficial ownership